Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.45    -0.20 (-1.20%)
Bid:
16.45
Ask:
16.70
Spread: 0.25 (1.52%)
Market Cap: £131.85m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Trading Update

1 Oct 2012 13:14

RNS Number : 6068N
Allocate Software PLC
01 October 2012
Β 

ο»Ώ

Β 

1 October 2012

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

Β 

Trading Update

Β 

Allocate Software, (AIM: ALL), the leading provider of workforce optimisation and corporate governance, risk & compliance software gives the following update on trading for the first three months of the current financial year ending 31 May 2013.

Β 

New licence sales have been lower than expected during the first quarter, which historically is the weakest period due to the summer slowdown, particularly in our UK healthcare business. This was as a result of delays in contracts closing, not competitive losses, and therefore the current pipeline for new business wins and licence renewals remains strong. The timing will have a knock-on effect on implementation and support revenues in the current quarter.

Β 

Progress in our growing portfolio of subscription-based product lines has been encouraging, with a number of these performing above management expectation, most notably our new Allocate Cloud service which we launched during the first quarter. It is however a function of the subscription model that the revenues from new business wins, recognised rateably over an extended period, will not significantly offset the impact of reduced licence and services revenues in the first half, though it does provide a more secure basis for the business in the longer term.

Β 

As a result of these factors and the changing business mix, the Board now expects that first half revenues will be lower than its original expectations, albeit broadly in line with the first half of the last financial year, and EBITDA will be below the prior year first half comparable.

Β 

Ian Bowles, Chief Executive, commented: "The Board continues to believe that the Company's new business pipeline and prospects remain strong, and will continue to drive the business towards meeting its financial targets for the full year. Whilst it is not possible to be certain that the first half revenue shortfall will be fully recouped in the second half, any resulting impact on profits will likely be mitigated by tight control over operating expenditure."

Β 

Enquiries:

Β 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

Β 

Tel: +44 (0) 20 7355 5555

Numis Securities Limited (NOMAD / Corporate Broker)

Nominated adviser - Michael Meade / Simon Willis /

Richard Thomas

Corporate Broking - James Black

Β 

Β 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James

John Bick

Β 

Tel: +44 (0) 20 7193 7463

+44 (0) 7525 324 431

Β 

Β 

Β 

About Allocate Software plc

Allocate Software plc is the leading workforce and compliance optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include: Healthcare and Defence.

At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.Allocatesoftware.com.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTUAAURURARRAA
Date   Source Headline
28th Nov 20137:00 amRNSBoard Appointment
26th Nov 20133:27 pmRNSResult of AGM and Scrip Dividend Scheme
14th Nov 20135:34 pmRNSScrip Dividend Scheme
6th Nov 20137:00 amRNSDirector/PDMR Shareholding
4th Nov 20134:50 pmRNSBlocklisting Application
4th Nov 201311:28 amRNSDirector/PDMR Shareholding
4th Nov 201310:06 amRNSNotification of Major Interest in Shares
4th Nov 20139:29 amRNSChange of Registered Office
4th Nov 20137:00 amRNSNotification of Major Interest in Shares
28th Oct 20133:15 pmRNSDirector/PDMR Shareholding
25th Oct 20139:15 amRNSNotification of Major Interest in Shares
21st Oct 20132:17 pmRNSNotice of AGM
21st Oct 20137:00 amRNSNotification of Major Interest in Shares
8th Oct 20133:24 pmRNSDirector/PDMR Shareholding
8th Oct 201311:39 amRNSNotification of Major Interest in Shares
7th Oct 20137:11 amRNSNotification of Major Interest in Shares
7th Oct 20137:00 amRNSBlocklisting Application
2nd Oct 201312:55 pmRNSExercise of Share Options
1st Oct 20133:29 pmRNSNotification of Major Interest in Shares
30th Sep 20135:17 pmRNSNotification of Major Interest in Shares
30th Sep 20139:46 amRNSNotification of Major Interest in Shares
30th Sep 20137:00 amRNSNotification of Major Interest in Shares
23rd Sep 20131:28 pmRNSNotification of Major Interest in Shares
23rd Sep 20137:09 amRNSRetirement of Director & Director Shareholding
23rd Sep 20137:05 amRNSExercise of Options & Director/PDMR Shareholding
20th Sep 20137:00 amRNSExercise of Share Options
18th Sep 20132:53 pmRNSDirector Shareholding
28th Aug 20137:00 amRNSExercise of Share Options
9th Aug 20139:01 amRNSExercise of Share Options
2nd Aug 20133:18 pmRNSExercise of Share Options
31st Jul 20131:30 pmRNSDividend Payment Date
23rd Jul 20137:00 amRNSFinal Results
24th Jun 20137:00 amRNSTrading Update
20th May 201310:19 amRNSExercise of Options
15th May 20131:08 pmRNSNotification of Major Interest in Shares
7th May 201310:25 amRNSExercise of Options
2nd May 20139:26 amRNSExercise of Options
29th Apr 20138:31 amRNSExercise of Options
26th Apr 20139:49 amRNSExercise of Options
27th Mar 20135:06 pmRNSExercise of Options
25th Mar 20133:30 pmRNSNotification of Major Interest in Shares
25th Mar 20137:05 amRNSNotification of Major Interest In Shares
22nd Mar 20132:16 pmRNSExercise of Options
6th Mar 20134:30 pmRNSHolding(s) in Company
6th Mar 20132:08 pmRNSHolding(s) in Company
26th Feb 20131:12 pmRNSExercise of Options
11th Feb 201310:59 amRNSHolding(s) in Company
11th Feb 201310:53 amRNSHolding(s) in Company
11th Feb 201310:51 amRNSHolding(s) in Company
5th Feb 20137:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.